These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 9360642)

  • 1. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
    Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O
    Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
    Wang HH; Lin CY
    Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis solution pH and Ca2+ concentration regulate peritoneal macrophage and mesothelial cell activation.
    Carozzi S; Caviglia PM; Nasini MG; Schelotto C; Santoni O; Pietrucci A
    ASAIO J; 1994; 40(1):20-3. PubMed ID: 8186487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
    Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
    Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased survival of mesothelial cells from the peritoneum in peritoneal dialysis fluid.
    Lai KN; Ho SK; Leung J; Tang SC; Chan TM; Li FK
    Cell Biol Int; 2001; 25(5):445-50. PubMed ID: 11401332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
    Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-8 in chronic renal failure and dialysis patients.
    Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y
    Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low CA++ level in effluent as a risk factor for the peritonitis in CAPD patients.
    Suga H; Honda H; Naganuma S; Yashuo M; Suzuki T; Teraoka S; Agishi T; Ota K
    Adv Perit Dial; 1990; 6():102-5. PubMed ID: 1982783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucose concentration on peritoneal inflammatory cytokines in continuous ambulatory peritoneal dialysis patients.
    Sayarlioglu H; Topal C; Sayarlioglu M; Dulger H; Dogan E; Erkoc R
    Mediators Inflamm; 2004 Apr; 13(2):119-21. PubMed ID: 15203553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A; Fernando RL; Varghese Z
    Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.